In April 2025, the FDA granted orphan drug designation to spesolimab-sbzo for the treatment of pyoderma gangrenosum. This ...

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis not only characterised by rapidly progressive skin ulceration, often triggered by trauma or surgery, but also associated with malignancy as ...

InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its Phase 3 trial for vilobelimab in pyoderma gangrenosum/PG would be ...

Find the latest InflaRx N.V. (IFRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

A Malaysian woman's TikTok video reveals the drastic skin changes she experienced during pregnancy, garnering millions of ...

Inflammatory Bowel Disease : Review in-depth clinical information, latest medical news, and guidelines on chronic inflammatory bowel disease symptoms, or IBD symptoms. Access information on ...

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold them for years.

INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025Phase 1/2 data announced by Staidson ...

INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025Phase 1/2 data announced by Staidson BioPharmaceuti ...